OBJECTIVE -To examine sex and racial/ethnic differences in cardiovascular risk factor treatment and control among individuals with diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA).
P
opulation-based health survey data suggest that sex and racial/ethnic disparities are present in diabetes process of care measures and cardiovascular risk factor control (1) (2) (3) (4) (5) (6) (7) (8) (9) . Available data also indicate that sex-specific race/ ethnicity differences are present in cardiovascular risk factor control, but these data are limited to Medicare and Veterans' Hospital patient populations (5,10 -13) . We therefore performed analyses of participants with diabetes in the MultiEthnic Study of Atherosclerosis (MESA) to examine sex and sex-specific racial/ ethnic differences in cardiovascular risk factor treatment and control.
RESEARCH DESIGN AND
METHODS -MESA is a multicenter cohort study of 6,814 men and women age 45-84 years with no clinical evidence of cardiovascular disease at time of enrollment (14) . Four MESA exam periods occurred between 2000 and 2007. The study was approved by the Institutional Review Board at all participating institutions, and all MESA participants provided informed consent. Criteria for recruitment, data collection methods, and laboratory techniques have been previously described (14) . Participants were classified as having diabetes if at exam 1 they had a fasting plasma glucose Ն126 mg/dl, used oral hypoglycemic agents and/or insulin, or reported a physician diagnosis of diabetes.
Statistical analysis
Multivariate models were used to calculate predicted means for lipid, blood pressure, and A1C levels. Prevalence ratios (PRs) were calculated for percentages of participants achieving cardiovascular risk factor goals using binomial regression, with adjustment for age, MESA site, socioeconomic status variables, and either sex or race/ethnicity. Potential effects of selective attrition on longitudinal results were examined using t tests to determine if participants lost to follow-up had higher mean cardiovascular risk factor levels compared with those retained in the study. Analyses were performed using SAS version 9.1. CONCLUSIONS -Among MESA participants with diabetes, at the baseline exam, a lower proportion of women achieved consensus treatment targets for SBP and LDL cholesterol, after adjustment for covariates. These differences were observed despite a greater reported use of blood pressure and lipid-lowering medications among women. African American and Hispanic women had lower proportions achieving consensus treatment goals for blood pressure and less reported use of aspirin compared with NHW women. The sex difference in LDL cholesterol and SBP control diminished over time.
RESULTS
Our findings are consistent with previous reports showing sex and racial/ ethnic differences in cardiovascular risk factor control among individuals with diabetes (2, 12, 13, 15) . Inconsistent findings have been reported regarding sex and racial/ethnic differences in use of medications for management of cardiovascular factors (3, 4, 8) .
There are several potential mechanisms for the sex and racial/ethnic differences we observed. Regression adjustment for socioeconomic status variables eliminated the significant sex difference in mean SBP. Socioeconomic variables may correlate with access to high-quality medical care and with personal behaviors that influence risk factor levels, including medication adherence, diet, and exercise. Our findings may also indicate a disparity in medication titration by physicians.
There are several limitations to our study. Information on medication use was self-reported and patient adherence was not recorded. Study participation may also have influenced treatment patterns because exam results were reported to the participants. Despite these limitations, our findings provide new information about sex and sex-specific race/ethnicity differences in cardiovascular risk factor treatment and control among individuals with diabetes in a contemporary multiethnic cohort with diverse sources of insurance.
In conclusion, we found that among subjects with diabetes in MESA, women had unfavorable cardiovascular risk factor profiles compared with men at baseline exam; however, these differences diminished over time. African American and Hispanic women had less favorable profiles than NHW women.
